Research progress in population pharmacokinetics of rituximab / 中国临床药理学与治疗学
Chinese Journal of Clinical Pharmacology and Therapeutics
; (12): 468-474, 2023.
Article
in Zh
| WPRIM
| ID: wpr-1014654
Responsible library:
WPRO
ABSTRACT
Rituximab, a chimeric human-mouse monoclonal antibody, has been used as a first-line treatment for CD20
Full text:
1
Database:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Clinical Pharmacology and Therapeutics
Year:
2023
Document type:
Article
